Human Immunity to Cas9 Could Threaten CRISPR’s Future – Seeker
Seeker |
Human Immunity to Cas9 Could Threaten CRISPR’s Future
Seeker One reason is to speed the development of Cas9 alternatives that aren’t derived from pathogenic bacteria. Promising results have already been achieved with a protein called Cpf1, so even if Cas9 immunity proves a serious issue, it doesn’t mean the end … |
New Scientist |
How ‘stem cell‘ clinics became a Wild West for dodgy treatments
New Scientist SHEILA DRYSDALE’S husband saw stem cells as a last, desperate attempt to ease his wife’s symptoms of dementia. Sadly, the same day she received treatment in Sydney – 20 December 2013 – Drysdale died, aged 75. In July 2016, the coroner investigating the … New Blood Stem Cell Harvest Method Could Speed Up TransplantsLymphoma News Today Researchers Derived Sensory Interneurons From Stem Cells for the First TimeEdgy Labs (blog) Longeveron developing stem cell treatments for Frailty, Alzheimers and other aging diseasesNext Big Future |
The Scientist |
EPO Revokes Broad’s CRISPR Patent
The Scientist In addition to the highly publicized patent dispute between the Broad and the University of California over the rights to CRISPR gene editing in the U.S., the Broad has been fighting to maintain a number of patents over the technology in Europe. The … UK: Broad Institute CRISPR Patent Revoked By EPOMondaq News Alerts |
|
Rockefeller University, Broad Institute Settle Dispute Over CRISPR IP
GenomeWeb In the dispute between Rockefeller and the Broad, Rockefeller had argued that one of its faculty members — Luciano Marraffini, who co-authored a key paper on the genome-editing technology with Broad’s Feng Zhang — should have been included on certain … |